drugset / Trial / NCT02191020

Efficacy and Safety Study of Total Glucosides of Paeony Combined With Acitretin to Treat Psoriasis

NCT02191020

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized, double blind, placebo parallel-controlled, multi-center clinical trial. Patients with psoriasis vulgaris were randomly divided into the experiment group (treated with TGP combined with acitretin capsules) and control group (treated with placebo combined with acitretin capsules).The treatment lasted 12 weeks. The efficacy and safety were evaluated at the baseline, as well as 2, 4, 8 and 12 weeks after the beginning of treatment.The investigator's hypothesis TGP combined with Acitretin Capsulesin is more safe and effective than Acitretin Capsulesin to treat Psoriasis Vulgaris.

Timeline

Start
2013-02
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acitretin Small molecule 20 mg Oral
Comparator Acitretin Small molecule 30 mg Oral
Subject Total glucosides of paeony Traditional medicine (herbal / TCM) 0.6 g Oral

Indications